Rohitha Inturi, MD
Family Medicine Physician in Liberal, Kansas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 147,760 in Family Medicine Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Rohitha Inturi, MD reported a CMS MIPS final score of 91.2/100 - above the 83.5 national average - and filed 4,092 Medicare Part D claims in 2023.
- 91.2/100
- MIPS score · +8 vs avg
- 4K
- Part D claims, 2023
- 85%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1669762167 · Family Medicine Physician
NPI-10 · ENUM-MID · TAX-MEGA · MIPS-ABOVE · RX-MID · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1669762167
- ENUM-MID 2011
- TAX-MEGA 148K Family Medicine
- MIPS-ABOVE 91.2/100
- RX-MID 4,092
- BOOK-LIGHT 1,933 in Kansas
- PHOTO-FINISH Farhad Aminzadeh · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Inturi · this pr…
Inturi · this provider
91.2 MIPS pts
- David Bank · hig…
David Bank
91.2 MIPS pts
- Farhad Aminzadeh…
Farhad Aminzadeh
91.2 MIPS pts
- Kevin Anderson ·…
Kevin Anderson
91.2 MIPS pts
- Blake Baird · near
Blake Baird
91.2 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Rohitha Inturi, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
91 ≥ 61st percentile 61% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Rohitha Inturi, MD sits
This provider among family medicine physician peers
Across the 21,266 family medicine physician providers who report both Medicare Part D prescribing and a MIPS quality score, Rohitha Inturi, MD writes more Part D claims than 61% of them and scores higher on MIPS quality than 61% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one family medicine physician peer from a representative sample of 60; the gold marker is Rohitha Inturi, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Rohitha Inturi, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Rohitha Inturi, MD?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Kansas
How Family Medicine Physician compares to other specialties among Kansas providers
Family Medicine Physician ranks #7 among Kansas's specialties (3.6% of in-state providers)
Each bar is a specialty's share of the Kansas provider total, by primary NUCC taxonomy. The highlighted bar is Family Medicine Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Rohitha Inturi, MD's 2023 MIPS final score plotted against the Family Medicine Physician national average
- MIPS Final Score
- 91.2/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Specialty volume Family Medicine Physician US NPIs
91.2/100 MIPS final score - 7.7 pts above the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Family Medicine Physician. Quality dim: 79.3.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1669762167 |
|---|---|
| Specialty | Family Medicine Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 04/18/2011 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Rohitha Inturi, MD's current license status, disciplinary history, and board certifications with the Kansas Board of Healing Arts in Kansas before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1669762167 is the unique 10-digit identifier CMS uses to link Inturi across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Alternative Payment Model
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Rohitha Inturi, MD. Source: openpaymentsdata.cms.gov.
Total received
$649
Largest payer
AstraZeneca Pharmaceuticals LP
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
15% brand-name claims vs 85% generic, on 4,092 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 9,196
- Total Day Supply
- 270,122
- Brand vs Generic
- 15% brand / 85% generic
- Brand Drug Cost
- $394K
- Generic Drug Cost
- $71K
- Antibiotic Claims
- 48
Patient Demographics
- Average Patient Age
- 71.4 years
- Avg HCC Risk Score
- 1.27
- Gender Split
- 68% female / 32% male
- Age Distribution
- <65: 61, 65-74: 162, 75-84: 104, 85+: 27
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Rohitha Inturi, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Atorvastatin Calcium
Atorvastatin Calcium
296 claims
- Levothyroxine Sodium
Levothyroxine Sodium
247 claims
- Lisinopril
Lisinopril
195 claims
- Metformin Hcl
Metformin Hcl
159 claims
- Pantoprazole Sodium
Pantoprazole Sodium
125 claims
- Gabapentin
Gabapentin
120 claims
- Omeprazole 102
Omeprazole
102 claims
- Trazodone Hcl 102
Trazodone Hcl
102 claims
| Drug | Claims |
|---|---|
| Atorvastatin Calcium | 296 |
| Levothyroxine Sodium | 247 |
| Lisinopril | 195 |
| Metformin Hcl | 159 |
| Pantoprazole Sodium | 125 |
| Gabapentin | 120 |
| Omeprazole | 102 |
| Trazodone Hcl | 102 |
| Amlodipine Besylate | 97 |
| Metoprolol Succinate | 81 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Family Medicine Physician Overview
How Rohitha Inturi, MD fits within the Family Medicine Physician landscape nationally.
Rohitha Inturi, MD's 4,092 claims are above the specialty average of 3,418.
Nationwide Family Medicine Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Inturi, both outside Kansas so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (91.2 here).
Same NPPES enumeration year (2011)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Family Medicine Physician Providers in Kansas
Other clinicians with the same primary specialty enrolled in Kansas, drawn from the same CMS NPPES roster as Inturi.
One of 1,933 Family Medicine Physician providers enrolled in Kansas, 5 are shown here.
Compare Family Medicine Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Rohitha Inturi, MD's specialty? ▼
How much does Rohitha Inturi, MD prescribe under Medicare Part D? ▼
What is Rohitha Inturi, MD's Medicare quality score? ▼
Where is Rohitha Inturi, MD located? ▼
What is Rohitha Inturi, MD's NPI number? ▼
Does Rohitha Inturi, MD prescribe more brand-name or generic drugs? ▼
How many Family Medicine Physician providers are there in the US? ▼
What drugs does Rohitha Inturi, MD prescribe most often? ▼
Does Rohitha Inturi, MD accept Medicare? ▼
How can I verify Rohitha Inturi, MD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.